Figure 2From: Evaluation of etoricoxib in patients undergoing total knee replacement surgery in a double-blind, randomized controlled trial Co-primary efficacy endpoints over 7 Days. Panel A shows Average Pain Intensity at Rest over 7 days. Panel B shows Postoperative Morphine Consumption over 7 days. Panel C shows Average Pain Intensity at Knee Flexion over 7 days.Back to article page